Science Daily -
18 Jun 2014 19:19
A new study has implicated the blocking of endocannabinoids -- signaling substances that are the brain's internal versions of the psychoactive chemicals in marijuana and hashish -- in the early pathology of Alzheimer's disease.
Share this Article